No Prescription |
 |
 | ||
|
Itraspor Mikro Sporanox |
|
| ||
No Prescription » Prescription Drugs 9 » Itraspor Mikro Sporanox Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Itraconazole capsules contain the active ingredient itraconazole which is a type of medicine called a triazole antifungal. It is used to treat infections caused by fungi.Itraconazole works by preventing fungi from producing a substance called ergosterol which is an essential component of fungal cell membranes. The cell membranes of fungi are vital for their survival. They keep unwanted substances from entering the cells and stop the contents of the cells from leaking out. Without ergosterol as part of the cell membrane the membrane is weakened and damaged and essential constituents of the fungal cells can leak out. This kills the fungi and hence clears up the infection. Itraconazole is used to treat a number of different types of fungal infections including those of the genitals mouth and skin. It is also useful for treating systemic (whole body) fungal infections and to prevent them from developing in people with an underactive immune system (for example due to AIDS).Itraconazole capsules are taken by mouth. Alternatively itraconazole may be administered via a drip into a vein (intravenous infusion) depending on the type and severity of the infection. The length of treatment will also depend on the type and severity of the infection.What is it used for?Fungal skin infections such as athlete's foot (tinea pedis) ringworm (tinea corporis) jock itch (tinea cruris) or pityriasis versicolor.Vaginal thrush (vulvovaginal candidiasis).Oral thrush (oropharyngeal candidiasis).Fungal nail infections.Fungal infection called histoplasmosis.Systemic fungal infections caused by Cryptococcus fungi (cryptococcosis) including cryptococcal meningitis.Systemic fungal infections caused by Aspergillus fungi (aspergillosis).Systemic fungal infections caused by Candida fungi (candidiasis).Preventing systemic fungal infections in people with AIDS or a low white blood cell count (neutropenia). Buy Itraspor Mikro Sporanox and other Prescription Drugs 9 products online at Medstore. Buy Online at Medstore - Click Here!
About Itraspor Mikro Sporanox: Product Type: Prescription Drugs 9 Itraspor Mikro ( Sporanox Generic Itraconazole ) - Product Origin: EU ( Turkey ) Itraspor Mikro (Sporanox Generic Itraconazole) Sporanox Generic Itraconazole 100mg 28 Capsules 56 Capsules Sporanox Generic Itraconazole Itraspor Mikro
View more Prescription Drugs 9 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
